What are the ACP recommendations for pharmacologic treatment of osteoporosis?

Updated: Sep 26, 2019
  • Author: Monique Bethel, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print

A clinical practice guideline from the American College of Physicians (ACP) recommends offering pharmacologic treatment to women with known osteoporosis, to reduce the risk of hip and vertebral fractures. [126] The ACP recommends use of any of the following agents:

  • Alendronate
  • Risedronate
  • Zoledronic acid
  • Denosumab

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!